Domestic News
1. South Korea's Neurophet Makes Full-Fledged Entry into Japanese Market with AI-Powered Image Analysis for Alzheimer's Disease
【Technological Innovation・AI・Market Entry】
Neurophet, a South Korean medical AI venture, exhibited at "ITEM2026 (International Technical Exhibition of Medical Imaging)" held at Pacifico Yokohama from April 17, 2026, where it unveiled "Neurophet AQUA AD," an AI software designed to support treatment monitoring for Alzheimer's disease, for the first time in Japan. This product features real-time monitoring of the treatment effects and side effects (such as ARIA) of anti-amyloid antibody drugs through quantitative analysis of MRI and PET scans. The company has partnered with Hokuyaku-Takeyama Holdings, Inc., a Japanese medical device and pharmaceutical wholesaler, with the aim of expanding its introduction to medical institutions across Japan.
Impact on the Industry: As new drug treatments for Alzheimer's disease become more widespread in Japan, there is a rapidly increasing demand for AI-powered image diagnostic support to ensure the safety and effectiveness of these treatments. The entry of leading overseas AI vendors is expected to further accelerate competition and technology adoption in Japan's medical imaging AI market.
2. Nidek Announces New Vision Testing Equipment Capable of Simultaneous Binocular Measurement
【New Product・Technological Innovation】
Nidek Co., Ltd., a manufacturer of ophthalmic medical devices, has announced new testing equipment capable of simultaneously measuring vision in both eyes. Compared to conventional methods that measure one eye at a time, this new equipment reduces discomfort and burden on the patient, enabling more accurate vision assessment in a state closer to natural vision.
Impact on the Industry: Shortening examination times and improving patient comfort in ophthalmological care are crucial issues in the aging Japanese market. The introduction of such user-centric designed testing equipment is expected to contribute to both the operational efficiency of clinics and patient satisfaction.
International News
3. Philips Receives FDA Approval for Verida, the World's First AI-Powered Spectral CT
【New Products and Regulatory Trends】
Royal Philips announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Spectral CT Verida, the world's first detector-based spectral CT system powered by AI. This system combines a dual-layer detector that continuously acquires spectral images with AI deep learning reconstruction technology. It achieves image reconstruction at 145 images per second and can complete a full-body scan in less than 30 seconds, enabling the processing of up to 270 examinations per day.
Impact on the Industry: This is a groundbreaking technology that simultaneously improves diagnostic accuracy across a wide range of fields, including radiology, cardiology, and oncology, and addresses the severe workflow bottlenecks in medical settings. The AI-driven reconstruction technology enhances the fundamental performance of CT, potentially serving as a strong driver to stimulate demand for hardware upgrades.
4. Rapid Medical Receives FDA Approval for Large Clot Retrieval Device TIGERTRIEVER 25
【New Products and Regulatory Trends】
Israel-based Rapid Medical announced that it has received FDA approval for its TIGERTRIEVER 25 clot retrieval device for stroke treatment and has successfully completed its first clinical use in the United States. The device features a 53mm capture length and incorporates unique real-time Force Control technology. This allows for the effective capture and retrieval of large thrombi in proximal large vessels such as the internal carotid artery (ICA) and middle cerebral artery (M1), which were previously difficult to treat with conventional devices.
Impact on the Industry: In endovascular treatment for acute ischemic stroke,
5. AVITA Medical Reports Favorable Interim Results for Dermal Matrix “Cohealyx”
【Clinical Data and Technological Innovation】
AVITA Medical, a company developing devices for burn and wound treatment, announced extremely favorable interim results from its clinical trial (Cohealyx-I) for Cohealyx, a collagen-based dermal matrix targeting full-thickness wounds. In an interim analysis of 40 patients, the average time to skin grafting was 13.6 days, representing a significant reduction of approximately 20 days compared to the existing literature-based benchmark (33.2 days) (statistical superiority p<0.001).
Impact on the Industry: In the treatment of severe wounds, reducing the wound bed preparation time directly leads to a lower risk of infection, shorter hospital stays, and reduced healthcare costs. This product has the potential to become a new benchmark for standard treatment, significantly enhancing the company's presence in the regenerative medicine and advanced wound care markets.
6. UK Government Allocates £1.5 Million to Support Introduction of FemTech Medical Devices
【Policy Trends and Market Environment】
As part of its newly announced “Women's Health Strategy,” the UK government has established a £1.5 million challenge fund to support the introduction of FemTech medical devices into the NHS (National Health Service). This funding will be used for promising FemTech development companies to collaborate with the NHS to build evidence and evaluate products in real clinical settings, contributing to addressing health disparities and building care models in local communities.
Impact on the Industry: This is an important move by the government to promote the application of technology to “unmet clinical needs” in the FemTech market, which has previously tended to focus on direct-to-consumer (D2C) and wellness areas. Support for evidence building through public funding will provide strong impetus for FemTech devices to be adopted into public health insurance as official medical devices.
References
- Korea Biomedical Review: Neurophet targets Japan with Alzheimer's imaging AI at ITEM 2026
- Chubu Keizai Shimbun: Ophthalmic medical device manufacturer Nidec launches new product for simultaneous measurement of vision in both eyes
- StockTitan: Philips wins FDA clearance for Verida spectral CT
- NeuroNews: Rapid Medical announces US FDA clearance of Tigertriever 25 alongside first clinical cases
- AVITA Medical: AVITA Medical Announces Positive Interim Results from Cohealyx® Study
- Med-Tech Insights: Government pledges £1.5 million for FemTech devices
Need help with Japan's medical device approval?
Our regulatory affairs consultants specializing in digestive endoscopy devices provide end-to-end support from strategy to document preparation. Contact us for a free initial consultation.
Free Consultation